BPC 157 Heals Perforated Stomach Injuries Through Nitric Oxide System Modulation
The peptide BPC 157 rapidly restored blood vessel function, stopped bleeding, and healed surgically perforated stomach injuries in rats by modulating the nitric oxide system.
Quick Facts
What This Study Found
BPC 157 at 0.01 μg/kg achieved complete healing of perforated stomach injuries by day 7 through rapid vascular restoration and NO-system modulation, outperforming pantoprazole and ranitidine.
Key Numbers
10 mL abdominal bath at 1 min post-perforation; vascular restoration in 1-15 min; reduced adhesions and defect at day 7.
How They Did This
Rat model with surgically perforated stomachs. Agents applied as abdominal bath at 1 min post-injury. Vascular, bleeding, and defect healing assessed at 1-15 min, day 1, and day 7. Gene expression (Cox2, VEGFa, Nos1-3, Nkap) and biochemical markers (MDA, NO) measured.
Why This Research Matters
Stomach perforation is a surgical emergency with significant morbidity. A peptide that can rapidly restore blood flow and promote healing through non-surgical means could complement existing treatments for gastrointestinal injuries.
The Bigger Picture
BPC 157 continues to demonstrate remarkable healing properties across multiple tissue types. This study adds to the growing evidence that it works through fundamental vascular and nitric oxide pathways, providing a mechanistic framework for its broadly observed cytoprotective effects.
What This Study Doesn't Tell Us
Animal study in rats — results may not directly translate to humans. The perforated stomach model is surgically induced, which may differ from clinical perforations. No human clinical trial data available for this application.
Questions This Raises
- ?Could BPC 157 be used as an adjunct to surgical repair of perforated ulcers in humans?
- ?What is the optimal route of administration for BPC 157 in gastrointestinal emergencies?
- ?How do the NO-modulating effects of BPC 157 compare across different tissue injury types?
Trust & Context
- Key Stat:
- Complete healing by day 7 BPC 157 at 0.01 μg/kg outperformed both pantoprazole and ranitidine
- Evidence Grade:
- Well-designed animal study with multiple comparison groups and mechanistic gene expression analysis. Pre-clinical evidence requiring human trials for clinical translation.
- Study Age:
- Published in 2021, adding to the extensive body of pre-clinical BPC 157 research.
- Original Title:
- Novel insight into Robert's cytoprotection: complex therapeutic effect of cytoprotective pentadecapeptide pentadecapeptide BPC 157 in rats with perforated stomach throughout modulation of nitric oxide-system. Comparison with L-arginine, ranitidine and pantoprazole therapy and L-NG-nitro-L-arginine methyl ester worsening.
- Published In:
- Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 72(6) (2021)
- Authors:
- Bilic, Z, Gojkovic, S(2), Kalogjera, L(2), Krezic, I, Malekinusic, D, Knezevic, M, Sever, M, Lojo, N, Kokot, A, Kasnik, K, Kralj, T, Vukojevic, J, Siroglavic, M, Peklic, M, Drmic, D, Milavic, M, Sikiric, S, Skorak, I, Brizic, I, Hriberski, K, Kubat, M, Vladic, J, Boban Blagaic, A, Tvrdeic, A, Skrtic, A, Seiwerth, S, Sikiric, P
- Database ID:
- RPEP-05283
Evidence Hierarchy
Frequently Asked Questions
What is BPC 157 and how does it heal the stomach?
BPC 157 is a synthetic peptide derived from a protein found in gastric juice. In this study, it healed stomach perforations by rapidly restoring blood vessel function, reducing bleeding, and modulating the nitric oxide system — key processes for tissue repair.
How does BPC 157 compare to standard stomach medications?
In this rat study, BPC 157 significantly outperformed both pantoprazole (a proton pump inhibitor) and ranitidine (an H2 blocker). Pantoprazole actually worsened blood vessel function, while ranitidine provided partial improvement. Only BPC 157 achieved complete healing by day 7.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-05283APA
Bilic, Z; Gojkovic, S; Kalogjera, L; Krezic, I; Malekinusic, D; Knezevic, M; Sever, M; Lojo, N; Kokot, A; Kasnik, K; Kralj, T; Vukojevic, J; Siroglavic, M; Peklic, M; Drmic, D; Milavic, M; Sikiric, S; Skorak, I; Brizic, I; Hriberski, K; Kubat, M; Vladic, J; Boban Blagaic, A; Tvrdeic, A; Skrtic, A; Seiwerth, S; Sikiric, P. (2021). Novel insight into Robert's cytoprotection: complex therapeutic effect of cytoprotective pentadecapeptide pentadecapeptide BPC 157 in rats with perforated stomach throughout modulation of nitric oxide-system. Comparison with L-arginine, ranitidine and pantoprazole therapy and L-NG-nitro-L-arginine methyl ester worsening.. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 72(6). https://doi.org/10.26402/jpp.2021.6.11
MLA
Bilic, Z, et al. "Novel insight into Robert's cytoprotection: complex therapeutic effect of cytoprotective pentadecapeptide pentadecapeptide BPC 157 in rats with perforated stomach throughout modulation of nitric oxide-system. Comparison with L-arginine, ranitidine and pantoprazole therapy and L-NG-nitro-L-arginine methyl ester worsening.." Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2021. https://doi.org/10.26402/jpp.2021.6.11
RethinkPeptides
RethinkPeptides Research Database. "Novel insight into Robert's cytoprotection: complex therapeu..." RPEP-05283. Retrieved from https://rethinkpeptides.com/research/bilic-2021-novel-insight-into-roberts
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.